| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 100.018 | 75 |
| GSM780708 | Untreated after 4 days (C2_1) | 121.361 | 78 |
| GSM780709 | Untreated after 4 days (C3_1) | 107.266 | 76 |
| GSM780719 | Untreated after 4 days (C1_2) | 79.9159 | 72 |
| GSM780720 | Untreated after 4 days (C2_2) | 97.204 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 84.4727 | 73 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 91.7472 | 74 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 95.309 | 75 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 90.8017 | 74 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 82.7235 | 72 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 93.5106 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 80.8959 | 72 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 114.402 | 77 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 118.654 | 78 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 93.1451 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 78.4607 | 71 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 96.441 | 75 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 81.3679 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 77.2399 | 71 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 84.9686 | 73 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 109.604 | 77 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 78.0273 | 71 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 97.22 | 75 |